本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

63.48
+0.97001.55%
盤後62.91-0.5700-0.90%16:50 EDT
成交量:221.99萬
成交額:1.41億
市值:59.84億
市盈率:-133.24
高:64.07
開:62.58
低:62.41
收:62.51
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:1.59
換手率:2.39%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:244.01
市盈率(LYR):-221.69

資料載入中...

2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/26

重要事件披露

Form 8-K - Current report
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities